Anxiety News and Research

Latest Anxiety News and Research

PHT comments on FDA's PRO Final Guidance

PHT comments on FDA's PRO Final Guidance

FDA issues Pfizer a Complete Response letter for Lyrica GAD monotherapy treatment

FDA issues Pfizer a Complete Response letter for Lyrica GAD monotherapy treatment

New energy receptor theory of brain function

New energy receptor theory of brain function

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

School intervention programs may promote psychological well-being among adolescents

School intervention programs may promote psychological well-being among adolescents

Women eligible for breast cancer screening with MRI decline to undergo the procedure, study shows

Women eligible for breast cancer screening with MRI decline to undergo the procedure, study shows

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

CIGNA suggests the 'To Do' list to stay healthy during this holiday season

CIGNA suggests the 'To Do' list to stay healthy during this holiday season

Study provides new definition on dyslexia

Study provides new definition on dyslexia

A program to reduce depression and isolation among the elderly during holiday season

A program to reduce depression and isolation among the elderly during holiday season

Cannabis can cause depression and anxiety in teenagers

Cannabis can cause depression and anxiety in teenagers

Somaxon Pharmaceuticals to meet FDA to discuss the NDA for Silenor for insomnia treatment

Somaxon Pharmaceuticals to meet FDA to discuss the NDA for Silenor for insomnia treatment

Neurocrine Biosciences to sell 4,784,689 shares of common stock to Venrock affiliates

Neurocrine Biosciences to sell 4,784,689 shares of common stock to Venrock affiliates

ASA offers practical ways for sufferers to take active role in treatment of pain

ASA offers practical ways for sufferers to take active role in treatment of pain

Professional treatment can benefit first responders to cope with emotional challenges

Professional treatment can benefit first responders to cope with emotional challenges

ARNMD meeting examines psychological and neurological aspects of PTSDs and traumatic brain injuries

ARNMD meeting examines psychological and neurological aspects of PTSDs and traumatic brain injuries

CIHR experts offer suggestions for stress-free holiday

CIHR experts offer suggestions for stress-free holiday

Flowers can uplift patients’ mood and reduce pain and anxiety

Flowers can uplift patients’ mood and reduce pain and anxiety

Naurex commences dosing in its GLYX-13 Phase I clinical trial for treatment-resistant depression

Naurex commences dosing in its GLYX-13 Phase I clinical trial for treatment-resistant depression

Dendritic cell changes suggest new strategy to identify and treat debilitating lung disease

Dendritic cell changes suggest new strategy to identify and treat debilitating lung disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.